Loading...

Skip to main content

Call us on + 1 (800) 604-9114 for more information about our products

Looking for specific datasheet Manual/COA/MSDS?
Request a Manual/COA/MSDS

Interested to get a quote about our products?
Request a Quote

Testing Data (IN VIVO APOPTOSIS DETECTION. SR-FLIVO was used to assess the effectiveness of arsenic trioxide (ATO) treatment on SCK mammary tumors in vivo. Using a window chamber to view tumors directly, SCK mammary tumor cells were grown under the skin of A/J mice for 7 days. Test mice were treated with ATO and the control mice received a placebo (24 hours). All mice were injected IV with SR-FLIVO and images were captured 30 minutes later. The control SCK tumor (A.) exhibited a base level of apoptosis as expected (18%, FACS data not shown), while the ATO-treated tumor (B.) exhibited a much higher level of apoptosis (36%, FACS data not shown). Bright spots indicate high levels of caspase activity within the tumor. ATO treatment doubled the level of caspase activity. Data courtesy of Dr. Robert Griffin, University of Minnesota.)

SR-FLIVO Poly Caspase Assay Kit

SR-FLIVO In vivo Poly Caspase Assay

Synonyms
SR-FLIVO Poly Caspase; SR-FLIVO In vivo Poly Caspase Assay; SR-FLIVO Poly Caspase assay kit
Ordering
For Research Use Only!
Preparation and Storage
2-8 degree C

Testing Data

(IN VIVO APOPTOSIS DETECTION. SR-FLIVO was used to assess the effectiveness of arsenic trioxide (ATO) treatment on SCK mammary tumors in vivo. Using a window chamber to view tumors directly, SCK mammary tumor cells were grown under the skin of A/J mice for 7 days. Test mice were treated with ATO and the control mice received a placebo (24 hours). All mice were injected IV with SR-FLIVO and images were captured 30 minutes later. The control SCK tumor (A.) exhibited a base level of apoptosis as expected (18%, FACS data not shown), while the ATO-treated tumor (B.) exhibited a much higher level of apoptosis (36%, FACS data not shown). Bright spots indicate high levels of caspase activity within the tumor. ATO treatment doubled the level of caspase activity. Data courtesy of Dr. Robert Griffin, University of Minnesota.)

Testing Data (IN VIVO APOPTOSIS DETECTION. SR-FLIVO was used to assess the effectiveness of arsenic trioxide (ATO) treatment on SCK mammary tumors in vivo. Using a window chamber to view tumors directly, SCK mammary tumor cells were grown under the skin of A/J mice for 7 days. Test mice were treated with ATO and the control mice received a placebo (24 hours). All mice were injected IV with SR-FLIVO and images were captured 30 minutes later. The control SCK tumor (A.) exhibited a base level of apoptosis as expected (18%, FACS data not shown), while the ATO-treated tumor (B.) exhibited a much higher level of apoptosis (36%, FACS data not shown). Bright spots indicate high levels of caspase activity within the tumor. ATO treatment doubled the level of caspase activity. Data courtesy of Dr. Robert Griffin, University of Minnesota.)

Testing Data

(Human colon carcinoma COLO205 cells were injected SC into female nude mice (tumors circled). After 27 days, animals were treated with a control (animal #1 not shown), TRAIL at 10 mg/kg (animal #2, right), or TRAIL at 25 mg/kg (animal #3 left). Animals were injected with SR-FLIVO at 1 and 4 hours to label caspase-positive tumor cells. Images were taken before treatment and at 1, 4, 6, and 24 hours post-treatment. Tumor nodules were excised at 24 hours and imaged (next). The data show that TRAIL induces apoptosis within 1 hour post treatment (a), and the level of apoptosis significantly increases posttreatment (b, c, d). COLO205 tumor cells are being killed; they fluoresce brightly with SR-FLIVO compared to no treatment. Data courtesy of Dr. Peter Lassota, Caliper Life Sciences/Xenogen (preliminary data without systems optimization shown).)

Testing Data (Human colon carcinoma COLO205 cells were injected SC into female nude mice (tumors circled). After 27 days, animals were treated with a control (animal #1 not shown), TRAIL at 10 mg/kg (animal #2, right), or TRAIL at 25 mg/kg (animal #3 left). Animals were injected with SR-FLIVO at 1 and 4 hours to label caspase-positive tumor cells. Images were taken before treatment and at 1, 4, 6, and 24 hours post-treatment. Tumor nodules were excised at 24 hours and imaged (next). The data show that TRAIL induces apoptosis within 1 hour post treatment (a), and the level of apoptosis significantly increases posttreatment (b, c, d). COLO205 tumor cells are being killed; they fluoresce brightly with SR-FLIVO compared to no treatment. Data courtesy of Dr. Peter Lassota, Caliper Life Sciences/Xenogen (preliminary data without systems optimization shown).)

Testing Data

(ACTIVATED CASPASEs IN MOUSE LUNG. Eric Hernady (University of Rochester Medical Center, Rochester, NY) labeled activated caspases in lung parenchymal cells after whole lung irradiation (RT). Mice were given either a 0Gy or 15Gy whole lung dose of gamma irradiation. Six hours post-irradiation, SR-FLIVO in vivo Apoptosis Kit was injected via mouse tail veins in 100µl boluses. The 1X FLIVO circulated for 18 hours prior to sacrifice. Mice received an intracardiac perfusion with heparinized saline followed by zinc-buffered formalin. Finally, we inflated the lungs prior to removal from the mouse. Tissues were processed, paraffin-embedded and sectioned (5µm). Nuclei were counterstained with DAPI, then lungs were imaged with a fluorescent microscope. Active caspases appear as a bright red cytoplasmic stain with discrete blue nuclei.)

Testing Data (ACTIVATED CASPASEs IN MOUSE LUNG. Eric Hernady (University of Rochester Medical Center, Rochester, NY) labeled activated caspases in lung parenchymal cells after whole lung irradiation (RT). Mice were given either a 0Gy or 15Gy whole lung dose of gamma irradiation. Six hours post-irradiation, SR-FLIVO in vivo Apoptosis Kit was injected via mouse tail veins in 100µl boluses. The 1X FLIVO circulated for 18 hours prior to sacrifice. Mice received an intracardiac perfusion with heparinized saline followed by zinc-buffered formalin. Finally, we inflated the lungs prior to removal from the mouse. Tissues were processed, paraffin-embedded and sectioned (5µm). Nuclei were counterstained with DAPI, then lungs were imaged with a fluorescent microscope. Active caspases appear as a bright red cytoplasmic stain with discrete blue nuclei.)
Related Product Information for SR-FLIVO Poly Caspase assay kit
Background/Introduction: FLIVO®(FLuorescence in vIVO) is a powerful method for assessing caspase activity in vivo. Similar to our FLICA® probes1,2, but optimized for whole live animal imaging, FLIVO probes are non-cytotoxic fluorescent inhibitors of caspases. SR-FLIVO poly caspase inhibitor probe contains the preferred binding sequence for all caspases, Val-Ala-Asp (VAD). This preferred poly caspase tripeptide binding sequence is labeled at the amino terminus end with a sulforhodamine B (SR) dye and linked at the carboxyl end to a fluoromethyl ketone (FMK) reactive entity. The resulting cell permeant, fluorescent molecule, SR-VAD-FMK, optimally excites at 550-580 nm and emits at 590-600 nm. The spectra for SR-FLIVO is shown in Figure 1. Apoptosis is an evolutionarily conserved process of programmed cell suicide. It is centered on a cascade of proteolytic enzymes called caspases that are triggered in response to pro-apoptotic signals. Like most other proteases, caspases are synthesized as pro-form precursors that undergo proteolytic maturation, either autocatalytically or in a cascade by enzymes with similar specificity3. Active caspase enzymes consist of two large (~20 kD) and two small (~10 kD) subunits that non-covalently associate to form a two heterodimer, tetrameric active caspase4-6. Once activated, caspases cleave protein substrates leading to the eventual disassembly of the cell. Caspases have been identified in organisms ranging from C. elegans to humans. Mammalian caspases play distinct roles in both apoptosis and inflammation. FLIVO kits provide a simple yet accurate method to detect caspase activity in vivo. To label cells containing elevated levels of active caspases, inject FLIVO intravenously and let it circulate ~60 minutes. Because the reagent is cell-permeant, it readily diffuses in and out of all cells it encounters as it circulates throughout the body. If there are active caspase enzymes inside a cell, FLIVO will form an irreversible covalent bond with a reactive cysteine on the large subunit of the caspase heterodimer, thereby inhibiting further enzymatic activity. The bound FLIVO probe will remain inside the cell as long as the cell membrane is intact. Any unbound FLIVO is removed from the circulation of the animal in about an hour. Additional time may be needed for FLIVO to clear other tissues. The remaining red fluorescent signal in the tissue after unbound FLIVO has cleared is a direct measure of caspase activity that occurred at the time the reagent was injected. Apoptotic cells will retain a higher concentration of FLIVO and fluoresce brighter than non-apoptotic cells. There is no interference from pro-caspases or inactive forms of the enzyme. If the treatment is causing cell death via apoptosis, apoptotic cells will have an elevated level of caspase activity relative to non-apoptotic or negative control cells and fluoresce red with FLIVO. After labeling with FLIVO, excised tissues can be counter-stained with other reagents and fixed or frozen. Once the animals have been injected with FLIVO and excess unbound FLIVO has cleared from the body of the animal, the tissues are ready for analysis and no further staining is necessary. Because FLIVO is a direct stain, it eliminates any false positives that may arise from manipulation of the tissue. This gives a true representation of the induction of apoptosis in vivo as a result of the experimental condition. Tissues can be viewed directly through a window chamber system or other accessible cavity, or thin tissue sections can be prepared after sacrificing the animal. Tissues labeled with FLIVO can be counter-stained with other reagents such as DAPI and fixed or frozen for future analysis. The fluorescence intensity can be quantified by excising the tissue and analyzing cells with a flow cytometer. SR-FLIVO optimally excites at 550-580 nm and has a peak emission at 590-600 nm (Figure 1).
Product Categories/Family for SR-FLIVO Poly Caspase assay kit
References
Kim JK, Byun MR, Maeng CH, Kim YR, Choi JW. Selective Targeting of Cancer Stem Cells (CSCs) Based on Photodynamic Therapy (PDT) Penetration Depth Inhibits Colon Polyp Formation in Mice. Cancers (Basel). 2020 Jan 14;12(1). pii: E203. doi: 10.3390/cancers12010203. Abstract
Kuchay, S;Giorgi, C;Simoneschi, D;Pagan, J;Missiroli, S;Saraf, A;Florens, L;Washburn, MP;Collazo-Lorduy, A;Castillo-Martin, M;Cordon-Cardo, C;Sebti, SM;Pinton, P;Pagano, M. PTEN counteracts FBXL2 to promote IP3R3- and Ca(2+)-mediated apoptosis limiting tumour growth. Nature. 2017 June 22. doi: 10.1038/nature22965. https://www.nature.com/nature/journal/vaop/ncurrent/full/nature22965.html. Full Article
Missiroli, S;Bonora, M;Patergnani, S;Poletti, F;Perrone, M;Gafà, R;Magri, E;Raimondi, A;Lanza, G;Tacchetti, C;Kroemer, G;Pandolfi, PP;Pinton, P;Giorgi, C. PML at Mitochondria-Associated Membranes Is Critical for the Repression of Autophagy and Cancer Development. Cell Report. 2016 August 30, Pages 2415-2427. doi:10.1016/j.celrep.2016.07.082. http://www.sciencedirect.com/science/article/pii/S2211124716310282. Full Article

Similar Products

Product Notes

The SR-FLIVO Poly Caspase (Catalog #AAA258408) is an Assay Kit and is intended for research purposes only. The product is available for immediate purchase. It is sometimes possible for the material contained within the vial of "SR-FLIVO Poly Caspase, Assay Kit" to become dispersed throughout the inside of the vial, particularly around the seal of said vial, during shipment and storage. We always suggest centrifuging these vials to consolidate all of the liquid away from the lid and to the bottom of the vial prior to opening. Please be advised that certain products may require dry ice for shipping and that, if this is the case, an additional dry ice fee may also be required.

Precautions

All products in the AAA Biotech catalog are strictly for research-use only, and are absolutely not suitable for use in any sort of medical, therapeutic, prophylactic, in-vivo, or diagnostic capacity. By purchasing a product from AAA Biotech, you are explicitly certifying that said products will be properly tested and used in line with industry standard. AAA Biotech and its authorized distribution partners reserve the right to refuse to fulfill any order if we have any indication that a purchaser may be intending to use a product outside of our accepted criteria.

Disclaimer

Though we do strive to guarantee the information represented in this datasheet, AAA Biotech cannot be held responsible for any oversights or imprecisions. AAA Biotech reserves the right to adjust any aspect of this datasheet at any time and without notice. It is the responsibility of the customer to inform AAA Biotech of any product performance issues observed or experienced within 30 days of receipt of said product. To see additional details on this or any of our other policies, please see our Terms & Conditions page.

Item has been added to Shopping Cart

If you are ready to order, navigate to Shopping Cart and get ready to checkout.

Looking for a specific manual?
Request a Manual

Request more Information

Please complete the form below and a representative will contact you as soon as possible.

Request a Manual

Please complete the form below and a representative will contact you as soon as possible.

Request a Quote

Please complete the form below and a representative will contact you as soon as possible.